News
Broad access to the fruits of NIH’s investments—whether in the form of data, results, or products—drives innovation. To advance this aim, NIH is launching a new policy to improve access to medical products developed from NIH-owned inventions. This policy emphasizes the importance of proactive
The National Institute of Standards and Technology (NIST) has published a report, written by David P. Leech and John T. Scott, titled Federal Agency Return on Investment in Foreign Patenting. This report details the U.S. federal agencies’ use of foreign patents to protect their intellectual property
Are you interested in licensing or co-developing SARS-CoV-2 targeting antibodies? Investigators at the National Cancer Institute (NCI) have isolated a panel of anti-receptor binding domain (RBD) single domain antibodies (also called ‘nanobodies’) from camel single domain (VHH) phage display
IRP Senior Investigator and Inventor Dr. Peter Choyke has been elected to the National Academy of Medicine (NAM). Dr. Choyke is the Director of the National Cancer Institute’s Molecular Imaging Branch. He was elected for his work on improving diagnosis and treatment through imaging technologies for